Member Publications - 1995
January
- Safety and immunogenicity of a gp120-depleted, inactivated HIV-1 immunogen: results of a double-blind, adjuvant controlled trial. Trauger RJ, Daigle AE, Giermakowska W, Moss RB, Jensen F, Carlo DJ. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;10 Suppl 2:S74-82.
- Viral load in peripheral blood mononuclear cells as surrogate for clinical progression. Ferre F, Moss RB, Daigle A, Richieri SP, Jensen F, Carlo DJ. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;10 Suppl 2:S51-6. Review.
February
March
- Alternative pharmacotherapies for steroid-dependent asthma. Moss RB. Chest. 1995 Mar;107(3):817-25. Review.
- Ca(2+)-inhibitable adenylyl cyclase modulates pulmonary artery endothelial cell cAMP content and barrier function. Stevens T, Nakahashi Y, Cornfield DN, McMurtry IF, Cooper DM, Rodman DM. Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2696-700.
- Gene therapy vectors as drug delivery systems. Afione SA, Conrad CK, Flotte TR. Clin Pharmacokinet. 1995 Mar;28(3):181-9. Review.
April
- Hypoxia potentiates nitric oxide synthesis and transiently increases cytosolic calcium levels in pulmonary artery endothelial cells. Hampl V, Cornfield DN, Cowan NJ, Archer SL. Eur Respir J. 1995 Apr;8(4):515-22.
- New drugs for cystic fibrosis lung disease. Moss RB. West J Med. 1995 Apr;162(4):354-5.
May
- Management of sinusitis in cystic fibrosis by endoscopic surgery and serial antimicrobial lavage. Reduction in recurrence requiring surgery. Moss RB, King VV. Arch Otolaryngol Head Neck Surg. 1995 May;121(5):566-72.
June
- Activation of CFTR chloride current by nitric oxide in human T lymphocytes. Dong YJ, Chao AC, Kouyama K, Hsu YP, Bocian RC, Moss RB, Gardner P. EMBO J. 1995 Jun 15;14(12):2700-7.
July
August
September
October
- Cystic fibrosis: pathogenesis, pulmonary infection, and treatment. Moss RB. Clin Infect Dis. 1995 Oct;21(4):839-49; quiz 850-1. Review.
November
December